Medial Septo Hippocampal Cholinergic Neurons In Neurodegeneration is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Medial septal cholinergic neurons form the primary cholinergic input to the hippocampus, originating in the medial septum and diagonal band of Broca. These neurons are essential for hippocampal-dependent memory and are severely affected in Alzheimer's disease.
¶ Location and Structure
The medial septum and diagonal band are located in the basal forebrain:
- Medial septum (MS): Vertical band of cholinergic neurons
- Diagonal band of Broca (DBB): Horizontal and vertical limbs
- Ch1-Ch2 groups: Cholinergic neurons projecting to hippocampus
- GABAergic neurons: Co-existing local circuit neurons
- Dense innervation of all hippocampal subfields
- Maximum in stratum radiatum and lacunosum-moleculare
- Non-synaptic, volume transmission
- Modulates hippocampal network states
- Critical for spatial memory
- Supports episodic memory formation
- Enables pattern separation
- Facilitates memory consolidation during sleep
- Drive theta oscillations (4-12 Hz)
- Phase precession in place cells
- Coordinate hippocampal-cortical communication
- Essential for memory encoding
- Severe loss of MS/DBB cholinergic neurons in AD
- Occurs early in disease progression
- Precedes significant hippocampal neuron loss
- Correlates with memory impairment severity
- Neurofibrillary tangle formation
- Amyloid toxicity
- Excitotoxicity
- Impaired axonal transport
- Neuroinflammation
- Reduced acetylcholine release
- Impaired theta oscillations
- Disrupted place cell function
- Memory encoding deficits
- Neurofibrillary tangles in MS neurons
- Hyperphosphorylated tau accumulation
- Early involvement in Braak staging
- Spreads through connected circuits
- Amyloid deposition in basal forebrain
- May initiate cholinergic vulnerability
- Aβ oligomer toxicity
- Disrupted cholinergic signaling
- Oxidative stress
- Mitochondrial dysfunction
- Impaired neurotrophic support
- Altered gene expression
- First-line AD treatments
- Increase available acetylcholine
- Provide modest cognitive benefit
- Delay symptom progression
- M1 muscarinic agonists
- Alpha-7 nicotinic modulators
- Choline acetyltransferase activators
- Acetylcholine reuptake inhibitors
- NGF delivery to basal forebrain
- BDNF-based therapies
- Anti-inflammatory compounds
- Antioxidant treatments
- Gene therapy for cholinergic enzymes
- Stem cell transplantation
- Optogenetic stimulation
- Deep brain stimulation of MS
The study of Medial Septo Hippocampal Cholinergic Neurons In Neurodegeneration has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Mesulam MM, Geula C. (1988). Nucleus basalis (Ch4) and cortical cholinergic innervation. J Comp Neurol.
- Hampel H, et al. (2019). The cholinergic system in AD. Brain.
- Ballinger EC, et al. (2016). Basal forebrain cholinergic circuits. J Neurosci.